[86] described that RG7834, a novel oral HBV gene expression inhibitor, could lessen the levels of viral proteins and reduce viremia. RG7834 is a little-molecule compound belonging to your dihydroquinolizinones chemical course just like RNAi but as a result of a unique mechanism. Sulfhydryl alkylating agent that inactivates NADP-dependent isocitrate https://joseonb211ume2.wikitidings.com/user